GRAL
GRAIL Inc. · Healthcare · Medical - Diagnostics & Research
Momentum inputs (comparable managers):
holder breadth -30.0% ·
share flow -14.9% ·
net new positions -20.0%
— formula
Broad distribution — falling shares and fewer holders
All ownership figures: tracked 13F managers only, common-stock positions, reporting period Q3 2024
| Quarter | Holders | Δ | Shares | Reported value | New | Exits |
|---|---|---|---|---|---|---|
| Q2 2026 | 111 | +3 | 19.70M | $1.34B | +13 | −9 |
| Q1 2026 | 110 | -6 | 18.56M | $959.35M | +4 | −11 |
| Q4 2025 | 117 | +2 | 17.78M | $1.52B | +3 | — |
| Q3 2025 | 18 | +1 | 10.99M | $649.07M | +2 | −2 |
| Q2 2025 | 15 | -1 | 10.50M | $537.63M | +1 | −2 |
| Q1 2025 | 13 | +1 | 6.08M | $155.14M | +2 | −1 |
| Q4 2024 | 12 | +2 | 5.32M | $94.90M | +3 | −1 |
| Q3 2024 | 9 | -6 | 3.74M | $51.49M | — | −6 |
| Q2 2024 | 15 | — | 4.39M | $67.54M | — | — |
| # | Manager | Shares | Δ shares | Value | Their weight | Held | ||
|---|---|---|---|---|---|---|---|---|
| 1 | PRIMECAP Management ✦ | 2.18M | +17.0% | $30.03M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 2 | AQR Capital Management ✦ | 485.82K | +3150.7% | $6.68M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 3 | AQR Capital Management ✦ | 485.82K | +3150.7% | $6.68M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 4 | Geode Capital Management ✦ (passive) | 423.97K | +0.5% | $5.84M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 5 | Geode Capital Management ✦ (passive) | 423.97K | +0.5% | $5.84M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 6 | Marshall Wace ✦ | 256.26K | +216.6% | $3.53M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 7 | Marshall Wace ✦ | 256.26K | +216.6% | $3.53M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 8 | Millennium Management ✦ | 208.39K | -15.4% | $2.87M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 9 | Citadel Advisors ✦ | 71.46K | -76.5% | $983,331 | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 10 | Norges Bank ✦ (passive) | 66.34K | -81.1% | $912,866 | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 11 | GAMCO Investors ✦ | 26.60K | +33.0% | $366,044 | 0.0% | ▲ Add | 2 | SEC ↗ |
| 12 | T. Rowe Price ✦ | 20.14K | +5.2% | $278,000 | 0.0% | ▲ Add | 2 | SEC ↗ |
“Their weight” = the position's share of that manager's reported 13F equity value — the conviction measure. ✦ = curated manager.
New buyers
| No new tracked buyers this quarter. |
Exited
| Wellington Management | $12.27M | was 0.0% |
| Soros Fund Management | $1.15M | was 0.0% |
| D. E. Shaw & Co. | $1.06M | was 0.0% |
| Capital World Investors | $1.03M | was 0.0% |
| Renaissance Technologies | $934,557 | was 0.0% |
| Baillie Gifford | $9,314 | was 0.0% |
Full-market context: across ALL 13F filers (SEC structured data, Q1 2026): 1 holders, 9.40K shares, $485 reported. This is a different, older period than the tracked-universe figures above and the two are never mixed.
What else this security's tracked holders most often hold — shared-ownership counts, not fundamental relationships.